Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
about
The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacinIn vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.Mutant selection window hypothesis updated.Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacinA unified anti-mutant dosing strategy.Quinolones: action and resistance updated.Emergence and spread of antibiotic resistance following exposure to antibiotics.In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.Mutant prevention concentrations of four carbapenems against gram-negative rods.Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study.Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.Comparative mutant prevention concentration and antibacterial activity of fluoroquinolones against Escherichia coli in diarrheic buffalo calves.Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin.Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa
P2860
Q33999695-F3C2D3A7-FB53-4A6F-8A24-9EE7DE82FC55Q35598576-009F1FC0-47A2-4D54-8B8C-B2D8E35C888EQ36187937-EEFCAD3E-D3E2-4EE1-91C6-BC0DA6722A96Q36728061-8A63EA97-E45F-4146-9CEA-1D1DEB7CA64FQ36744859-2E0E1B13-3580-4A36-A879-9CF62A35CEC3Q37188136-028DEE8C-1DE2-4C25-9408-882DEB7277A9Q37595559-289646CE-FEFB-48CA-A8EC-D0148D7E83B3Q37896674-E1F33061-F473-404E-81F0-831C65FEE5E1Q38977280-4F79A4EC-EECD-4B0E-A92F-8A1EA19A01A2Q39108922-2D47B18C-3343-4A15-BFAE-5D5FB2565F71Q40749260-AF0FB121-7EF0-4481-9C9B-47989DE52551Q40982184-6CDE9482-77D7-439A-9E2D-DCE12DFD325CQ41833848-DE37BFD7-5274-438B-9F7F-E230B7804E4AQ42127654-969C348E-527A-4B0D-8329-944ECB5F2159Q45952913-E0FCB3FD-9AAB-4862-B4BA-ADCBBC76505CQ52863922-F9D6305C-4991-4857-BE6A-F6783C1F31B3Q57240410-7B96AE49-43B1-4C06-9614-E1C1A6A8C753
P2860
Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@en
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@nl
type
label
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@en
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@nl
prefLabel
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@en
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@nl
P2093
P1476
Mutant prevention concentratio ...... n with Pseudomonas aeruginosa.
@en
P2093
Glen T Hansen
Joseph M Blondeau
Karl Drlica
P304
P356
10.1016/J.IJANTIMICAG.2005.10.005
P50
P577
2006-01-19T00:00:00Z